Lucy Patrick K. — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Lucy Patrick K. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Patrick K. Lucy is a director of Dyadic International Inc., a worldwide biotechnology platform company known for its C1 gene expression technology based on Thermothelomyces heterothallic fungus. In the SEC filing with CIK 0001612843 dated 2026-01-06, he is listed as having no purchases or sales in that filing, indicating a focused governance role. In this capacity, he contributes to board oversight and strategic governance during the company’s development of industrial enzyme and protein-production platforms.
Role
Director
Notability
28/100
Board memberships
Dyadic International Inc.
Awards & honors
Serves on the board of directors of Dyadic International Inc., contributing governance oversight.
Participates in strategic discussions related to the company’s C1 gene expression platform and industrial enzyme production.
Patrick K. Lucy is a director of Dyadic International Inc., a worldwide biotechnology platform company known for its C1 gene expression technology based on Thermothelomyces heterothallic fungus. In the SEC filing with CIK 0001612843 dated 2026-01-06, he is listed as having no purchases or sales in that filing, indicating a focused governance role. In this capacity, he contribut…
Where can I see all of Lucy Patrick K.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
